---
authors:
- Ebell, Mark H
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/38648840/
file_path: 2024/04/high-dose-recombinant-influenza-vaccine-nnt-3000-to-prevent.md
issue: '4'
keywords:
- Humans
- Influenza, Human
- Vaccines, Synthetic
- Hospitalization
- Influenza Vaccines
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Influenza Vaccines
- Influenza, Human
- Hospitalization
- Vaccines, Synthetic
original_format: PubMed
pages: '372'
patient_population: Adults
peer_reviewed: true
pmid: '38648840'
processed_date: '2025-07-30'
publication_date: '2024-04-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-10'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: 'High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More Infection,
  No Impact on Hospitalization.'
topics:
- Family Medicine
volume: '109'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '38648840'
  title: 'High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More
    Infection, No Impact on Hospitalization.'
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: University of Georgia, Athens, Ga.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '109'
    issue: '4'
  publication_info:
    year: '2024'
    month: '04'
    full_date: '2024-04-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Influenza Vaccines
    major_topic: true
    qualifiers:
    - qualifier: administration & dosage
      major_topic: false
  - descriptor: Influenza, Human
    major_topic: true
    qualifiers:
    - qualifier: prevention & control
      major_topic: false
  - descriptor: Hospitalization
    major_topic: true
    qualifiers:
    - qualifier: statistics & numerical data
      major_topic: false
  - descriptor: Vaccines, Synthetic
    major_topic: false
    qualifiers:
    - qualifier: administration & dosage
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '38648840'
  title: 'High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More
    Infection, No Impact on Hospitalization.'
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2024 Apr
- pmid: '38091531'
  title: Recombinant or Standard-Dose Influenza Vaccine in Adults under 65 Years of
    Age.
  authors:
  - name: Hsiao A
    authtype: Author
    clusterid: ''
  - name: Yee A
    authtype: Author
    clusterid: ''
  - name: Fireman B
    authtype: Author
    clusterid: ''
  - name: Hansen J
    authtype: Author
    clusterid: ''
  - name: Lewis N
    authtype: Author
    clusterid: ''
  - name: Klein NP
    authtype: Author
    clusterid: ''
  source: N Engl J Med
  pubdate: 2023 Dec 14
- pmid: '32100009'
  title: Relative Effectiveness of Influenza Vaccines Among the United States Elderly,
    2018-2019.
  authors:
  - name: Izurieta HS
    authtype: Author
    clusterid: ''
  - name: Chillarige Y
    authtype: Author
    clusterid: ''
  - name: Kelman J
    authtype: Author
    clusterid: ''
  - name: Wei Y
    authtype: Author
    clusterid: ''
  - name: Lu Y
    authtype: Author
    clusterid: ''
  - name: Xu W
    authtype: Author
    clusterid: ''
  - name: Lu M
    authtype: Author
    clusterid: ''
  - name: Pratt D
    authtype: Author
    clusterid: ''
  - name: Wernecke M
    authtype: Author
    clusterid: ''
  - name: MaCurdy T
    authtype: Author
    clusterid: ''
  - name: Forshee R
    authtype: Author
    clusterid: ''
  source: J Infect Dis
  pubdate: 2020 Jun 29
- pmid: '1811378'
  title: Safety of the subunit influenza vaccine in asthmatic children.
  authors:
  - name: Ghirga G
    authtype: Author
    clusterid: ''
  - name: Ghirga P
    authtype: Author
    clusterid: ''
  - name: Rodin√≤ P
    authtype: Author
    clusterid: ''
  - name: Presti A
    authtype: Author
    clusterid: ''
  source: Vaccine
  pubdate: 1991 Dec
- pmid: '27314982'
  title: Recombinant hemagglutinin influenza vaccine provides broader spectrum protection.
  authors:
  - name: Dunkle LM
    authtype: Author
    clusterid: ''
  - name: Izikson R
    authtype: Author
    clusterid: ''
  source: Expert Rev Vaccines
  pubdate: 2016 Aug
---

# High-Dose Recombinant Influenza Vaccine: NNT = 3,000 to Prevent One More Infection, No Impact on Hospitalization.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 109, No. 4 | 2024-04-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/38648840/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Influenza Vaccines, Influenza, Human, Hospitalization, Vaccines, Synthetic

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/38648840/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
